Healthcare -
Biotechnology - NASDAQ - US
$ 21.93
1.2 %
$ 3.16 B
Market Cap
-7.95
P/E
DNLI - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss DNLI - Denali Therapeutics Inc.
643 K
LAST VALUE
50.24%
2 YEAR CAGR
24.50%
5 YEAR CAGR
0.00%
10 YEAR CAGR